CSR to Increase Access to Medicines: Lessons and Opportunities for the Middle East

Joseph Antoun

Chapter 3 in CSR in the Middle East, 2012, pp 49-71 from Palgrave Macmillan

Abstract: Abstract Corporate social responsibility (CSR) aimed at increasing access to medicines (ATM) has recently witnessed evolutionary and revolutionary changes, both at the conceptual and implementation levels. Indeed, with the global burden of disease shifting from acute to chronic diseases, the philanthropy based model of CSR that responds to short-term ATM needs becomes insufficient to mitigate ATM for chronic conditions. New CSR options, strategic to business revenues and therefore sustained by the private sector, could provide longer-term ATM solutions.

Keywords: Corporate Social Responsibility; Middle East; Corporate Social Responsibility Activity; Corporate Social Responsibility Strategy; Parallel Trade (search for similar items in EconPapers)
Date: 2012
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-1-137-26620-0_4

Ordering information: This item can be ordered from
http://www.palgrave.com/9781137266200

DOI: 10.1057/9781137266200_4

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().